HIGHLIGHTS
- who: Igor Kudryavtsev et al. from the Institute of Experimental Medicine, Saint Petersburg, Russia have published the Article: In Vitro Stimulation with Live SARS-CoV-2 Suggests Th17 Dominance In Virus-Specific CD4+ T Cell Response after COVID-19, in the Journal: Vaccines 2022, 1544 of /2022/
- what: The authors investigated the SARS-CoV-2-specific CD4+ T cell phenotype in comparison with H1N1 influenza-specific CD4+ T cells. Another limitation is that the study participants had unknown influenza infection status; however, this study was conducted in a period when SARS-CoV-2 were 11 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.